Glycine receptor antagonist
This page covers all Glycine receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glycine receptor.
Targets
Phase 3 pipeline (2)
- bitopertin [RO4917838] level 2 · Hoffmann-La Roche · Psychiatry
Bitopertin is a glycine receptor antagonist. - bitopertin [RO4917838] · Hoffmann-La Roche · Psychiatry
Bitopertin is a glycine receptor antagonist.
Patent intelligence
- glycine receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates